3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Completed
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
5
Gastrointestinal
2
Plasma cell
1
Genitourinary
1
Conditions
Rectal Neoplasms
2
Neoplasms by Site
1
Neoplasms
1
Colonic Neoplasms
1
Carcinoma
1
Interventions
Fluorouracil
616
Oxaliplatin
579
Gemcitabine
492
Capecitabine
445
Leucovorin
427
Irinotecan
390
Bevacizumab
330
Cisplatin
320
Radiotherapy
245
Cetuximab
215
Sorafenib
167
pembrolizumab
152
Docetaxel
150
Paclitaxel
140
Nivolumab
128
Albumin-Bound Paclitaxel
108
130-nm albumin-bound paclitaxel
108
Folfox protocol
101
Panitumumab
95
Erlotinib Hydrochloride
95
Surgical Procedures, Operative
86
regorafenib
84
S 1 (combination)
81
Drug Therapy
80
Radiation
69
Carboplatin
65
Neoadjuvant Therapy
64
Colonoscopy
64
Radiosurgery
63
Surveys and Questionnaires
60
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
L-BLP25
×
Gastrointestinal
×
Clear all
NCT01462513
2018-02-13
LICC
Johannes Gutenberg University Mainz
Phase 2
Completed
122 enrolled
NCT01507103
2017-01-13
SPRINT
Merck KGaA, Darmstadt, Germany
Phase 2
Completed
124 enrolled
9 charts